Cancer Research Grants  Metabolism and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schindl, M.
Right arrow Articles by Birner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schindl, M.
Right arrow Articles by Birner, P.
[Cancer Research 61, 5703-5706, August 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Overexpression of Id-1 Protein Is a Marker for Unfavorable Prognosis in Early-Stage Cervical Cancer1

Monika Schindl, Georg Oberhuber, Andreas Obermair, Sebastian F. Schoppmann, Barbara Karner and Peter Birner2

Institute of Clinical Pathology [M. S., G. O., S. F. S., B. K., P. B.], and Department of Gynecology and Obstetrics [A. O.], University of Vienna, A-1090 Vienna, Austria

Inhibitor of differentiation/DNA binding (Id) proteins are transcription factors, involved in cell cycle regulation and neoangiogenesis. Using immunohistochemistry, we investigated the prognostic influence of Id-1, Id-2, and Id-3 expression in 89 patients with cervical cancer stage pT1b. In univariate and multivariate analysis, patients with strong or moderate expression of Id-1 had a significant shorter overall survival time (P = 0.0144, log-rank test) and disease-free survival time (P = 0.0107, log-rank test) compared with those with low or absent Id-1 expression. Id-1 expression is an independent prognostic marker in early-stage cervical cancer.




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
R. Salomon, L. Young, D. MacLeod, X.-L. Yu, and Q. Dong
Probasin Promoter-driven Expression of ID1 Is not Sufficient for Carcinogenesis in Rodent Prostate
J. Histochem. Cytochem., June 1, 2009; 57(6): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qian and X. Chen
ID1, Inhibitor of Differentiation/DNA Binding, Is an Effector of the p53-dependent DNA Damage Response Pathway
J. Biol. Chem., August 15, 2008; 283(33): 22410 - 22416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Lin, Z. Zhou, L. Zheng, S. Alber, S. Watkins, P. Ray, N. Kaminski, Y. Zhang, and D. Morse
Cross Talk between Id1 and Its Interactive Protein Dril1 Mediate Fibroblast Responses to Transforming Growth Factor-{beta} in Pulmonary Fibrosis
Am. J. Pathol., August 1, 2008; 173(2): 337 - 346.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Kamalian, J. R. Gosney, S. S. Forootan, C. S. Foster, Z. Z. Bao, C. Beesley, and Y. Ke
Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance
Clin. Cancer Res., April 15, 2008; 14(8): 2318 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Gautschi, C. G. Tepper, P. R. Purnell, Y. Izumiya, C. P. Evans, T. P. Green, P. Y. Desprez, P. N. Lara, D. R. Gandara, P. C. Mack, et al.
Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer
Cancer Res., April 1, 2008; 68(7): 2250 - 2258.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhang, M.-T. Ling, Q. Wang, C.-K. Lau, S. C. L. Leung, T. K. Lee, A. L. M. Cheung, Y.-C. Wong, and X. Wang
Identification of a Novel Inhibitor of Differentiation-1 (ID-1) Binding Partner, Caveolin-1, and Its Role in Epithelial-Mesenchymal Transition and Resistance to Apoptosis in Prostate Cancer Cells
J. Biol. Chem., November 16, 2007; 282(46): 33284 - 33294.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Li, P. Y. Cheung, X. Wang, S. W. Tsao, M. T. Ling, Y. C. Wong, and A. L.M. Cheung
Id-1 activation of PI3K/Akt/NF{kappa}B signaling pathway and its significance in promoting survival of esophageal cancer cells
Carcinogenesis, November 1, 2007; 28(11): 2313 - 2320.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. K. Lee, R. T.P. Poon, A. P. Yuen, M. T. Ling, X. H. Wang, Y. C. Wong, X. Y. Guan, K. Man, Z. Y. Tang, and S. T. Fan
Regulation of Angiogenesis by Id-1 through Hypoxia-Inducible Factor-1{alpha}-Mediated Vascular Endothelial Growth Factor Up-regulation in Hepatocellular Carcinoma
Clin. Cancer Res., December 1, 2006; 12(23): 6910 - 6919.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe
Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-T. Ling, W.-K. Kwok, M. K. Fung, W. Xianghong, and Y.-C. Wong
Proteasome mediated degradation of Id-1 is associated with TNF{alpha}-induced apoptosis in prostate cancer cells
Carcinogenesis, February 1, 2006; 27(2): 205 - 215.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-T. Ling, T. C.M. Lau, C. Zhou, C. W. Chua, W. K. Kwok, Q. Wang, X. Wang, and Y.-C. Wong
Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF)
Carcinogenesis, October 1, 2005; 26(10): 1668 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kebebew, M. Peng, P. A. Treseler, O. H. Clark, Q.-Y. Duh, D. Ginzinger, and R. Miner
Id1 Gene Expression Is Up-Regulated in Hyperplastic and Neoplastic Thyroid Tissue and Regulates Growth and Differentiation in Thyroid Cancer Cells
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6105 - 6111.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. W. Cheung, M.-t. Ling, S. W. Tsao, Y.C. Wong, and X. Wang
Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells
Carcinogenesis, June 1, 2004; 25(6): 881 - 887.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-T. Ling, X. Wang, D. T. Lee, P.C. Tam, S.-W. Tsao, and Y.-C. Wong
Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R)
Carcinogenesis, April 1, 2004; 25(4): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-P. Coppe, Y. Itahana, D. H. Moore, J. L. Bennington, and P.-Y. Desprez
Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression
Clin. Cancer Res., March 15, 2004; 10(6): 2044 - 2051.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Fong, Y. Itahana, T. Sumida, J. Singh, J.-P. Coppe, Y. Liu, P. C. Richards, J. L. Bennington, N. M. Lee, R. J. Debs, et al.
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
PNAS, November 11, 2003; 100(23): 13543 - 13548.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. K.-W. Lee, K. Man, M.-T. Ling, X.-H. Wang, Y.-C. Wong, C.-M. Lo, R. T.-P. Poon, I. O.-L. Ng, and S.-T. Fan
Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway
Carcinogenesis, November 1, 2003; 24(11): 1729 - 1736.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. G. Shepherd and M. W. Nachtigal
Identification of a Putative Autocrine Bone Morphogenetic Protein-Signaling Pathway in Human Ovarian Surface Epithelium and Ovarian Cancer Cells
Endocrinology, August 1, 2003; 144(8): 3306 - 3314.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Tang, G. M. Gordon, M. G. Muller, M. Dahiya, and K. E. Foreman
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells
J. Virol., May 15, 2003; 77(10): 5975 - 5984.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Schindl, S. F. Schoppmann, T. Strobel, H. Heinzl, C. Leisser, R. Horvat, and P. Birner
Level of Id-1 Protein Expression Correlates with Poor Differentiation, Enhanced Malignant Potential, and More Aggressive Clinical Behavior of Epithelial Ovarian Tumors
Clin. Cancer Res., February 1, 2003; 9(2): 779 - 785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.